Lopez-Cerda, Marta http://orcid.org/0000-0002-6511-0302
Lorenzo-Sanz, Laura http://orcid.org/0000-0001-6477-2163
da Silva-Diz, Victoria
Llop, Sandra
Penin, Rosa M.
Bermejo, Josep Oriol
de Goeij-de Haas, Richard
Piersma, Sander R.
Pham, Thang V.
Jimenez, Connie R.
Martin-Liberal, Juan
MuƱoz, PurificaciĆ³n http://orcid.org/0000-0002-3751-2099
Article History
Received: 11 March 2024
Accepted: 7 July 2024
First Online: 29 July 2024
Declarations
:
: The protocol for patient sample collection was supervised and approved by the Ethical Committee of Clinical Research of the Hospital Universitario de Bellvitge (Barcelona, Spain), PR392/20. All patients were informed beforehand and their signed consent to participate in the study was obtained. All procedures were carried out in accordance with the relevant guidelines and regulations of the Declaration of Helsinki.Animal housing and handling, and all procedures involving mice were approved by the Bellvitge Biomedical Research Institute (IDIBELL) Ethics Committee (Barcelona, Spain) (18003, DMAH10402) and conformed to the guidelines of Spanish national regulations and the Generalitat de Catalunya.
: All authors agreed to publish this manuscript.
: JML reports lecturing fees from Astellas, Bristol-Myers Squibb, MSD, Novartis, Pierre Fabre, Pfizer, Roche, Sanofi; advisory fees from Bristol-Myers Squibb, Highlight Therapeutics, Novartis, Pierre Fabre, Roche, Sanofi; and travel grants from Bristol-Myers Squibb, MSD, Novartis, Pierre Fabre, Pfizer, Roche, Ipsen. The authors have no additional competing interests.